People who bank adipose tissue for decades eventually ask an uncomfortable question: what happens to that tissue if they die first? This guide covers banked tissue succession as the published sources treat it, which is mostly by silence. It is legal information, not legal advice.
TLDR No federal tissue rule and no published source reviewed here states what happens to privately banked autologous tissue when the depositor dies. The storage agreement controls, so read it, name a contact, tell your family, ask the bank in writing, and consult an attorney. Tissue banked for autologous use is labeled for the depositor’s own use, and any other use is a separate regulatory question. Banking does not guarantee eligibility, access, or clinical benefit from any future therapy.
Important Disclaimer: Save My Fat does not provide FDA-approved treatments or cures for any disease. Banking adipose tissue today does not guarantee eligibility, access, or clinical benefit from any future therapy, clinical trial, or medical program. No adipose-derived stem cell product currently has FDA approval for any condition. All content is for educational purposes only and does not constitute medical advice. Patients must consult their own licensed healthcare professionals regarding all medical decisions.
You signed a storage agreement, your tissue is in storage, and the plan is to keep it there for a long time. Then a relative asks the question nobody likes: what happens to it if you are not around? Most families have no idea.
Save My Fat has published more than two hundred educational articles on adipose tissue banking, the FDA framework, state stem cell laws, and the adipose-derived cell trial pipeline since February 2026. This is one of the few questions where the primary sources are almost silent. Save My Fat connects patients and providers with a U.S. tissue bank; it does not collect, process, store, or treat tissue.
Who Owns Banked Tissue, and Does the Law Settle Banked Tissue Succession?
The storage contract is the only published source of an answer. Courts have left open questions about stored tissue as property, and the federal storage and tracking rules in 21 CFR Part 1271 say nothing about ownership or death.
A 2010 legal analysis in HEC Forum by Roche reviewed the three U.S. cases on stored tissue as property: Moore v. Regents of the University of California (1988, 1990), Greenberg v. Miami Children’s Research Institute (2003), and Washington University v. Catalona (2007). All three concerned research samples, not paid autologous storage, and none addressed the depositor’s death. The Roche analysis concludes that “some unresolved questions remain, including what exercising those rights means on a practical level.”
A 2023 review by Devi and colleagues in Life states that “the parties own the samples taken as per the contract” for private banks, while public banks own donated units. That Devi review points straight back to the agreement you signed.
The text of section 1271.260 covers storage area control, temperature, expiration dating, and corrective action, with nothing on ownership or transfer when the donor dies. Under section 1271.290, tracking must run “from the donor to the consignee or final disposition; and the consignee or final disposition to the donor,” and the section is silent on heirs. Our guide to tissue ownership law covers the broader property question.
What Does the Storage Agreement Usually Decide?
The storage agreement is where banked tissue succession is settled, if it is settled anywhere. No statute fills the gap, so the terms you signed apply.
This post does not describe any bank’s terms, only categories to look for. The first is a named successor: can you designate a person who may give instructions if you cannot? The second is a next of kin default: if you name nobody, who will the bank listen to? The third is disposition instructions: may you state in advance whether storage continues or ends?
The fourth is non-payment, often the practical trigger after a death: what happens when storage fees stop? The fifth is bank closure, and who gets notified. If your agreement is silent on any of these, get an answer in writing. Our post on questions before banking covers other terms worth reading.
What Does the Uniform Anatomical Gift Act Cover, and What Does It Leave Out?
The Uniform Anatomical Gift Act governs donation of all or part of a body after death for transplantation, therapy, research, or education. It does not govern private storage contracts or tissue banked for the donor’s own use.
The Revised Uniform Anatomical Gift Act was approved by the Uniform Law Commission in July 2006. Its act text defines an anatomical gift as “a donation of all or part of a human body to take effect after the donor’s death for the purposes of transplantation, therapy, research, or education.” The act contains no provision on autologous storage or private storage contracts. It is a model act, and state versions may differ.
Whether a will, a power of attorney, or a health care directive can reach a private storage agreement is a state law question these sources do not answer. Take it to an attorney in your state; this post does not give estate law advice.
What Could a Family Member Do With Autologous Tissue?
The sources do not answer this, and the required labels point away from use by anyone else. Tissue banked for autologous use is labeled for the depositor’s own use, and use by any other person is a different regulatory question.
Under section 1271.90, no donor eligibility determination, screening, or testing is required for autologous use. In exchange, the tissue must be prominently labeled “FOR AUTOLOGOUS USE ONLY” if stored for autologous use, and “NOT EVALUATED FOR INFECTIOUS SUBSTANCES” unless all applicable screening and testing was done. Part 1271 defines autologous use as transfer of cells or tissue “back into the individual from whom the cells or tissue were recovered.”
Use in a relative would not be autologous use, and none of the sources reviewed here address it. This post does not say a relative can use the tissue, because no source says so. No adipose-derived stem cell product has FDA approval for any condition, research on adipose-derived cells remains early stage, and questions about future use belong with a licensed provider. Our post on family eligibility explains why banking is framed as one person’s tissue.
How Do Cord Blood Banks Handle Transfer, and Is That a Precedent?
The nearest published precedent is cord blood, where one source states that ownership of privately banked cord blood passes to the child at majority. It is a thin precedent, and it does not describe the death of a parent.
A 2009 ethics debate article in BMC Medical Ethics by Serrano-Delgado and colleagues, written from Mexico, notes “the fact that ownership of the cord stored in private banks passes to the child (donor) once he/she has come of age.” The Serrano-Delgado article rests that point on a cited reference, not U.S. law. For adult adipose banking, no source reviewed here describes a transfer at death, which is why the agreement carries the weight. Our guide to managing banked cells covers decisions after storage.
What Should You Do Now About Banked Tissue Succession?
Read the agreement, name a contact, tell your family, ask the bank in writing, and consult an attorney. Each step closes a gap the published sources leave open.
The table turns that into questions and where each answer should live.
| Question to ask | Where the answer usually lives | What the sources say |
|---|---|---|
| Can I name a successor or contact? | The storage agreement or a bank form | The contract controls (Devi 2023) |
| Who does the bank listen to if I name nobody? | The storage agreement | Not addressed in Part 1271 or the UAGA |
| What happens when fees stop after a death? | The non-payment terms | Not addressed in any source reviewed |
| What happens if the bank closes? | The closure terms | Not addressed in any source reviewed |
| What is the tissue labeled for? | Section 1271.90 labels | “FOR AUTOLOGOUS USE ONLY” |
| How long must the bank keep records? | Section 1271.270 | At least 10 years after administration, or after distribution, disposition, or expiration if that date is unknown |
The retention rule in section 1271.270 is a duty about records, not the tissue itself.
Frequently Asked Questions
Does 21 CFR Part 1271 say what happens to my banked tissue if I die?
No. Section 1271.260 sets storage controls such as temperature and expiration dating, and section 1271.290 requires tracking from donor to final disposition and back. Neither mentions ownership, heirs, or the death of the donor.
Can I leave my banked adipose tissue to a relative in my will?
The sources reviewed here do not answer that, and this post does not give estate law advice. Tissue stored for autologous use carries the label “FOR AUTOLOGOUS USE ONLY” under section 1271.90, and use by another person is a different regulatory question. Ask the bank in writing, then take the answer to an attorney.
If I name a successor, does that mean the tissue can be used in a future therapy?
No. Naming a contact only settles who can give instructions to the bank. It creates no treatment pathway. Banking does not guarantee eligibility for any trial or program, and any future use depends on FDA status at that time and your own licensed healthcare professionals.
Key Takeaways
Banked tissue succession is decided by the storage agreement, not by federal rule. The Uniform Anatomical Gift Act governs donation after death and has no provision on private storage. Tissue banked for autologous use is labeled for one person, and any other use is a separate regulatory question. Read your agreement, name a contact, tell your family, ask the bank in writing, and consult an attorney. Banking does not guarantee eligibility, access, or benefit from any future therapy.
Save My Fat connects patients and providers with a U.S.-based tissue bank. It is not a tissue bank, a laboratory, a medical practice, or a treatment provider. Stem cell and regenerative medicine regulations vary by state, including specific informed-consent and disclosure requirements in Florida, Utah, California, Georgia, and Tennessee governing tissue and stem cell services. Banking adipose tissue does not connect patients to any treatment pathway, and any future use depends on FDA regulatory status, physician guidance, and the availability of approved or investigational pathways at that time.
Readers weighing adipose tissue banking for potential future use can review current pricing or bring their succession questions to the contact page.
Save My Fat works with a U.S.-based tissue bank for laboratory processing and storage.
This article is for educational purposes only and does not constitute medical or legal advice. Please consult your own licensed healthcare provider before making any decisions about treatment or research participation.
About the author: Oscar Tellez is the founder and CEO of Save My Fat. He holds a Bachelor of Science in Exercise Science and Health Promotion from Florida Atlantic University. He has spent a decade in the regenerative medicine industry across product distribution, laboratory and vendor relationships, and provider training. He is not a licensed clinician, and this article is educational, not medical advice.
Related guide: longevity and tissue banking.
